Loading...

Adaptive Biotechnologies Corp (NASDAQ:ADPT)

11.52 USD -0.33 USD ( -2.78% )
Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist

Relative Value

The Relative Value of one ADPT stock under the Base Case scenario is 9.87 USD. Compared to the current market price of 11.52 USD, Adaptive Biotechnologies Corp is Overvalued by 14%.

Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

ADPT Relative Value
Base Case
9.87 USD
Overvaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

Multiples Across Competitors

ADPT Competitors Multiples
Adaptive Biotechnologies Corp Competitors

Country Company Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Adaptive Biotechnologies Corp
NASDAQ:ADPT
1.6B USD 10.3 N/A N/A N/A
IN
Divi's Laboratories Ltd
NSE:DIVISLAB
996B INR 11.1 33.6 24.9 27.1
CN
WuXi Biologics (Cayman) Inc
HKEX:2269
295B HKD 24.8 75.4 73.8 73.8
CN
WuXi AppTec Co Ltd
SSE:603259
268B CNY 8.9 38 40.3 40.3
IN
Syngene International Ltd
NSE:SYNGENE
239B INR 9 60.8 31.1 52.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
234B USD 5.5 31.5 20.3 26.4

See Also

Similar Stocks